The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning
Abstract
Ischemic preconditioning (Pre-con) is an adaptive response triggered by a brief ischemia applied before a prolonged coronary occlusion. We tested the hypothesis that repetitive ischemia applied during early reperfusion, i.e., postconditioning (Post-con), is cardio-protective by attenuating reperfusion injury. In anesthetized open-chest dogs, the left anterior descending artery (LAD) was occluded for 60 min and reperfused for 3 h. In controls (n = 10), there was no intervention. In Pre-con (n = 9), the LAD was occluded for 5 min and reperfused for 10 min before the prolonged occlusion. In Post-con (n = 10), at the start of reperfusion, three cycles of 30-s reperfusion and 30-s LAD reocclusion preceded the 3 h of reperfusion. Infarct size was significantly less in the Pre-con (15 +/- 2%, P < 0.05) and Post-con (14 +/- 2%, P < 0.05) groups compared with controls (25 +/- 3%). Tissue edema (% water content) in the area at risk was comparably reduced in Pre-con (78.3 +/- 1.2, P < 0.05) and Post-con (79.7 +/- 0.6, P < 0.05) versus controls (81.5 +/- 0.4). Polymorphonuclear neutrophil (PMN) accumulation (myeloperoxidase activity, Deltaabsorbance.min-1.g tissue-1) in the area at risk myocardium was comparably reduced in Post-con (10.8 +/- 5.5, P < 0.05) and Pre-con (13.4 +/- 3.4, P < 0.05) versus controls (47.4 +/- 15.3). Basal endothelial function measured by PMN adherence to postischemic LAD endothelium (PMNs/mm2) was comparably attenuated by Post-con and Pre-con (15 +/- 0.6 and 12 +/- 0.6, P < 0.05) versus controls (37 +/- 1.5), consistent with reduced expression of P-selectin on coronary vascular endothelium in Post-con and Pre-con. Endothelial function assessed by the maximal vasodilator response of postischemic LAD to acetylcholine was significantly greater in Post-con (104 +/- 6%, P < 0.05) and Pre-con (109 +/- 5%, P < 0.05) versus controls (71 +/- 8%). Plasma malondialdehyde (microM/ml), a product of lipid peroxidation, was significantly less at 1 h of reperfusion in Post-con (2.2 +/- 0.2, P < 0.05) versus controls (3.2 +/- 0.3) associated with a decrease in superoxide levels revealed by dihydroethidium staining in the myocardial area at risk. These data suggest that Post-con is as effective as Pre-con in reducing infarct size and preserving endothelial function. Post-con may be clinically applicable in coronary interventions, coronary artery bypass surgery, organ transplantation, and peripheral revascularization where reperfusion injury is expressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Murry, C. E., Jennings, R. B., & Reimer, K. A. (1986) · Circulation · doi:10.1161/01.cir.74.5.1124 · Cited by 7,812
Jolly, S. R., Kane, W. J., Bailie, M. B., Abrams, G. D., & Lucchesi, B. R. (1984) · Circulation Research · doi:10.1161/01.res.54.3.277 · Cited by 900
Bolli, R., Patel, B. S., Jeroudi, M. O., Lai, E. K., & McCay, P. B. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113621 · Cited by 687
The role of neutrophils in myocardial ischemia–reperfusion injury
Jordan, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00187-x · Cited by 646
Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 1
Kloner, R. A., & Jennings, R. B. (2001) · Circulation · doi:10.1161/hc4801.100038 · Cited by 634
Miller, F. J., Gutterman, D. D., Rios, C. D., Heistad, D. D., & Davidson, B. L. (1998) · Circulation Research · doi:10.1161/01.res.82.12.1298 · Cited by 623
Deutsch, E., Berger, M., Kussmaul, W. G., Hirshfeld, J. W., Herrmann, H. C., & Laskey, W. K. (1990) · Circulation · doi:10.1161/01.cir.82.6.2044 · Cited by 594
Ma, X. L., Weyrich, A. S., Lefer, D. J., & Lefer, A. M. (1993) · Circulation Research · doi:10.1161/01.res.72.2.403 · Cited by 491
Fundamentals of Reperfusion Injury for the Clinical Cardiologist
Verma, S., Fedak, P. W. M., Weisel, R. D., Butany, J., Rao, V., Maitland, A., Li, R.-K., Dhillon, B., & Yau, T. M. (2002) · Circulation · doi:10.1161/01.cir.0000016602.96363.36 · Cited by 446
Preconditioning in Cardiomyocytes Protects by Attenuating Oxidant Stress at Reperfusion
Hoek, T. L. V., Becker, L. B., Shao, Z.-H., Li, C.-Q., & Schumacker, P. T. (2000) · Circulation Research · doi:10.1161/01.res.86.5.541 · Cited by 311
Cited by
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Yellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
Hausenloy, D. J., & Yellon, D. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62874 · Cited by 2,357
“In contrast to unimpeded reperfusion, IPost is intermittent reperfusion of the acute ischemic myocardium, which has been reported to prevent myocardial reperfusion injury and reduce MI size by 40%–50% (61).”
Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury
Murphy, E., & Steenbergen, C. (2008) · Physiological Reviews · doi:10.1152/physrev.00024.2007 · Cited by 1,465
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
Piot, C., Croisille, P., Staat, P., Thibault, H., Rioufol, G., Mewton, N., Elbelghiti, R., Cung, T. T., Bonnefoy, E., Angoulvant, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071142 · Cited by 1,339
Myocardial ischaemia–reperfusion injury and cardioprotection in perspective
Heusch, G. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0403-y · Cited by 1,234
Evolving Therapies for Myocardial Ischemia/Reperfusion Injury
Ibáñez, B., Heusch, G., Ovize, M., & Van de Werf, F. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.032 · Cited by 1,009
Postconditioning the Human Heart
Staat, P., Rioufol, G., Piot, C., Cottin, Y., Cung, T. T., L’Huillier, I., Aupetit, J.-F., Bonnefoy, E., Finet, G., André-Fouët, X., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.558122 · Cited by 999
Bøtker, H. E., Kharbanda, R., Schmidt, M. R., Bøttcher, M., Kaltoft, A. K., Terkelsen, C. J., Munk, K., Andersen, N. H., Hansen, T. M., Trautner, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62001-8 · Cited by 989
Heusch, G. (2015) · Circulation Research · doi:10.1161/circresaha.116.305348 · Cited by 811
Calabrese, E. J., Bachmann, K. A., Bailer, A. J., Bolger, P. M., Borak, J., Cai, L., Cedergreen, N., Cherian, M. G., Chiueh, C. C., Clarkson, T. W., et al. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.02.015 · Cited by 750
Ferdinandy, P., Schulz, R., & Baxter, G. F. (2007) · Pharmacological Reviews · doi:10.1124/pr.107.06002 · Cited by 744
Cardiovascular remodelling in coronary artery disease and heart failure
Heusch, G., Libby, P., Gersh, B., Yellon, D., Böhm, M., Lopaschuk, G., & Opie, L. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60107-0 · Cited by 734
Lavie, L. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.07.003 · Cited by 681
Heusch, G., & Gersh, B. J. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw224 · Cited by 676
Tsang, A., Hausenloy, D. J., Mocanu, M. M., & Yellon, D. M. (2004) · Circulation Research · doi:10.1161/01.res.0000138303.76488.fe · Cited by 661
Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for Therapy
Turer, A. T., & Hill, J. A. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.03.032 · Cited by 634
Ischaemic conditioning and reperfusion injury
Hausenloy, D. J., & Yellon, D. M. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.5 · Cited by 579
Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease
Lai, R. C., Chen, T. S., & Lim, S. K. (2011) · Regenerative Medicine · doi:10.2217/rme.11.35 · Cited by 553
Ferdinandy, P., Hausenloy, D. J., Heusch, G., Baxter, G. F., & Schulz, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008300 · Cited by 562
Postconditioning Inhibits Mitochondrial Permeability Transition
Argaud, L., Gateau-Roesch, O., Raisky, O., Loufouat, J., Robert, D., & Ovize, M. (2005) · Circulation · doi:10.1161/01.cir.0000151290.04952.3b · Cited by 561
Kin, H. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.01.006 · Cited by 561
Remote ischaemic preconditioning: underlying mechanisms and clinical application
Hausenloy, D. J., & Yellon, D. M. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn114 · Cited by 557
Cardioprotection: chances and challenges of its translation to the clinic
Heusch, G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60916-7 · Cited by 546
Guidelines for experimental models of myocardial ischemia and infarction
Lindsey, M. L., Bolli, R., Canty, J. M., Du, X.-J., Frangogiannis, N. G., Frantz, S., Gourdie, R. G., Holmes, J. W., Jones, S. P., Kloner, R. A., et al. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00335.2017 · Cited by 526
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection
Hausenloy, D. J., & Yellon, D. M. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9026-1 · Cited by 509
Ovize, M., Baxter, G. F., Di Lisa, F., Ferdinandy, P., Garcia-Dorado, D., Hausenloy, D. J., Heusch, G., Vinten-Johansen, J., Yellon, D. M., & Schulz, R. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq129 · Cited by 502
Self-citationYang, X.-M., Proctor, J. B., Cui, L., Krieg, T., Downey, J. M., & Cohen, M. V. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.05.060 · Cited by 500
Myocardial Ischemia Reperfusion Injury: From Basic Science to Clinical Bedside
Frank, A., Bonney, M., Bonney, S., Weitzel, L., Koeppen, M., & Eckle, T. (2012) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253211436350 · Cited by 487
Nrf2 at the heart of oxidative stress and cardiac protection
Chen, Q. M., & Maltagliati, A. J. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00041.2017 · Cited by 474
Survival kinases in ischemic preconditioning and postconditioning
HAUSENLOY, D., & YELLON, D. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.017 · Cited by 472
Tao, L., Gao, E., Jiao, X., Yuan, Y., Li, S., Christopher, T. A., Lopez, B. L., Koch, W., Chan, L., Goldstein, B. J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.666941 · Cited by 453
Hausenloy, D. J., Tsang, A., & Yellon, D. M. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.03.001 · Cited by 449
Cardioprotection: Nitric Oxide, Protein Kinases, and Mitochondria
Heusch, G., Boengler, K., & Schulz, R. (2008) · Circulation · doi:10.1161/circulationaha.108.805242 · Cited by 441
Mitochondrial Dysfunction and Myocardial Ischemia-Reperfusion: Implications for Novel Therapies
Lesnefsky, E. J., Chen, Q., Tandler, B., & Hoppel, C. L. (2017) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103335 · Cited by 440
The ubiquitous role of nitric oxide in cardioprotection
Jones, S. P., & Bolli, R. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.09.011 · Cited by 434
Long-Term Benefit of Postconditioning
Thibault, H., Piot, C., Staat, P., Bontemps, L., Sportouch, C., Rioufol, G., Cung, T. T., Bonnefoy, E., Angoulvant, D., Aupetit, J.-F., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.729780 · Cited by 430
Bøtker, H. E., Hausenloy, D., Andreadou, I., Antonucci, S., Boengler, K., Davidson, S. M., Deshwal, S., Devaux, Y., Di Lisa, F., Di Sante, M., et al. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0696-8 · Cited by 423
Myocardial reperfusion injury: looking beyond primary PCI
Fröhlich, G. M., Meier, P., White, S. K., Yellon, D. M., & Hausenloy, D. J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht090 · Cited by 415
TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure
Kleinbongard, P., Heusch, G., & Schulz, R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.05.002 · Cited by 409
Endothelial Mitochondria: Contributing to Vascular Function and Disease
Davidson, S. M., & Duchen, M. R. (2007) · Circulation Research · doi:10.1161/01.res.0000261970.18328.1d · Cited by 381
Sanada, S., Komuro, I., & Kitakaze, M. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00553.2011 · Cited by 381
Mitochondria and Ischemia/Reperfusion Injury
HONDA, H. M., KORGE, P., & WEISS, J. N. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1341.022 · Cited by 377
The myocardial JAK/STAT pathway: From protection to failure
BOENGLER, K., HILFIKERKLEINER, D., DREXLER, H., HEUSCH, G., & SCHULZ, R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.002 · Cited by 362
Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury
ARGAUD, L., GATEAUROESCH, O., MUNTEAN, D., CHALABREYSSE, L., LOUFOUAT, J., ROBERT, D., & OVIZE, M. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.12.001 · Cited by 358
Hausenloy, D. J., Garcia-Dorado, D., Bøtker, H. E., Davidson, S. M., Downey, J., Engel, F. B., Jennings, R., Lecour, S., Leor, J., Madonna, R., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx049 · Cited by 356
Self-citationRole of Glycogen Synthase Kinase-3β in Cardioprotection
Juhaszova, M., Zorov, D. B., Yaniv, Y., Nuss, H. B., Wang, S., & Sollott, S. J. (2009) · Circulation Research · doi:10.1161/circresaha.109.197996 · Cited by 352
Zhao, H., Sapolsky, R. M., & Steinberg, G. K. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600348 · Cited by 340
Gomez, L., Paillard, M., Thibault, H., Derumeaux, G., & Ovize, M. (2008) · Circulation · doi:10.1161/circulationaha.107.755066 · Cited by 335
Garlid, K. D., Dos Santos, P., Xie, Z.-J., Costa, A. D. T., & Paucek, P. (2003) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(03)00109-9 · Cited by 332
Lecour, S. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.03.019 · Cited by 328
Loss of cardioprotection with ageing
Boengler, K., Schulz, R., & Heusch, G. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp033 · Cited by 328
Hausenloy, D. J., Botker, H. E., Engstrom, T., Erlinge, D., Heusch, G., Ibanez, B., Kloner, R. A., Ovize, M., Yellon, D. M., & Garcia-Dorado, D. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw145 · Cited by 325
Ong, S.-B., Samangouei, P., Kalkhoran, S. B., & Hausenloy, D. J. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.11.005 · Cited by 323
Biology of Endoplasmic Reticulum Stress in the Heart
Groenendyk, J., Sreenivasaiah, P. K., Kim, D. H., Agellon, L. B., & Michalak, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.227033 · Cited by 312
Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery
Hausenloy, D. J., Barrabes, J. A., Bøtker, H. E., Davidson, S. M., Di Lisa, F., Downey, J., Engstrom, T., Ferdinandy, P., Carbrera-Fuentes, H. A., Heusch, G., et al. (2016) · Basic Research in Cardiology · doi:10.1007/s00395-016-0588-8 · Cited by 308
Self-citationPreconditioning and postconditioning: Underlying mechanisms and clinical application
Hausenloy, D. J., & Yellon, D. M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.10.029 · Cited by 303
Heusch, G., Musiolik, J., Gedik, N., & Skyschally, A. (2011) · Circulation Research · doi:10.1161/circresaha.111.255604 · Cited by 303
Layland, J., Carrick, D., Lee, M., Oldroyd, K., & Berry, C. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.02.009 · Cited by 297
Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine
KIN, H., ZATTA, A., LOFYE, M., AMERSON, B., HALKOS, M., KERENDI, F., ZHAO, Z., GUYTON, R., HEADRICK, J., & VINTENJOHANSEN, J. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.02.015 · Cited by 297
Self-citationCohen, M. V., Yang, X.-M., & Downey, J. M. (2007) · Circulation · doi:10.1161/circulationaha.106.675710 · Cited by 297
Kerendi, F., Kin, H., Halkos, M. E., Jiang, R., Zatta, A. J., Zhao, Z. –., Guyton, R. A., & Vinten–Johansen, J. (2005) · Basic Research in Cardiology · doi:10.1007/s00395-005-0539-2 · Cited by 292
Self-citationLoukogeorgakis, S. P., Williams, R., Panagiotidou, A. T., Kolvekar, S. K., Donald, A., Cole, T. J., Yellon, D. M., Deanfield, J. E., & MacAllister, R. J. (2007) · Circulation · doi:10.1161/circulationaha.106.653782 · Cited by 287
Ischemia-reperfusion Injury in the Brain: Mechanisms and Potential Therapeutic Strategies
L, L., & X, W. (2016) · Biochemistry & Pharmacology: Open Access · doi:10.4172/2167-0501.1000213 · Cited by 285
Preconditioning and postconditioning: United at reperfusion
Hausenloy, D. J., & Yellon, D. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.005 · Cited by 285
Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection
Heusch, G., Boengler, K., & Schulz, R. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-009-0080-9 · Cited by 285
Sun, H.-Y., Wang, N.-P., Kerendi, F., Halkos, M., Kin, H., Guyton, R. A., Vinten-Johansen, J., & Zhao, Z.-Q. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01244.2003 · Cited by 284
Self-citationSchmidt, M. R., Smerup, M., Konstantinov, I. E., Shimizu, M., Li, J., Cheung, M., White, P. A., Kristiansen, S. B., Sorensen, K., Dzavik, V., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00617.2006 · Cited by 277
Postconditioning: Reduction of reperfusion-induced injury
ZHAO, Z., & VINTENJOHANSEN, J. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.024 · Cited by 272
Self-citationChen, Q., Camara, A. K. S., Stowe, D. F., Hoppel, C. L., & Lesnefsky, E. J. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00270.2006 · Cited by 271
Mitochondria as a Drug Target in Ischemic Heart Disease and Cardiomyopathy
Walters, A. M., Porter, G. A., & Brookes, P. S. (2012) · Circulation Research · doi:10.1161/circresaha.112.265660 · Cited by 271
LIM, S., DAVIDSON, S., HAUSENLOY, D., & YELLON, D. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.04.022 · Cited by 269
The mitochondrial permeability transition pore as a target for preconditioning and postconditioning
Hausenloy, D. J., Ong, S.-B., & Yellon, D. M. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0010-x · Cited by 268
Historical Perspective on the Pathology of Myocardial Ischemia/Reperfusion Injury
Jennings, R. B. (2013) · Circulation Research · doi:10.1161/circresaha.113.300987 · Cited by 268
Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway
Lacerda, L., Somers, S., Opie, L. H., & Lecour, S. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp274 · Cited by 261
Involvement of Nrf2 in myocardial ischemia and reperfusion injury
Shen, Y., Liu, X., Shi, J., & Wu, X. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.190 · Cited by 261
Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade
PHILIPP, S., YANG, X., CUI, L., DAVIS, A., DOWNEY, J., & COHEN, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.014 · Cited by 259
Hausenloy, D. J., Chilian, W., Crea, F., Davidson, S. M., Ferdinandy, P., Garcia-Dorado, D., van Royen, N., Schulz, R., & Heusch, G. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvy286 · Cited by 259
Lønborg, J., Kelbæk, H., Vejlstrup, N., Jørgensen, E., Helqvist, S., Saunamäki, K., Clemmensen, P., Holmvang, L., Treiman, M., Jensen, J. S., et al. (2010) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.109.905521 · Cited by 258
Chiari, P. C., Bienengraeber, M. W., Pagel, P. S., Krolikowski, J. G., Kersten, J. R., & Warltier, D. C. (2005) · Anesthesiology · doi:10.1097/00000542-200501000-00018 · Cited by 258
Ischemic Postconditioning in Pigs: No Causal Role for RISK Activation
Skyschally, A., van Caster, P., Boengler, K., Gres, P., Musiolik, J., Schilawa, D., Schulz, R., & Heusch, G. (2009) · Circulation Research · doi:10.1161/circresaha.108.186429 · Cited by 255
Penna, C., Rastaldo, R., Mancardi, D., Raimondo, S., Cappello, S., Gattullo, D., Losano, G., & Pagliaro, P. (2006) · Basic Research in Cardiology · doi:10.1007/s00395-006-0584-5 · Cited by 255
Coronary microvascular obstruction: the new frontier in cardioprotection
Heusch, G. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0756-8 · Cited by 253
Protein S -Nitrosylation and Cardioprotection
Sun, J., & Murphy, E. (2010) · Circulation Research · doi:10.1161/circresaha.109.209452 · Cited by 205
Cardioprotection during cardiac surgery.
Hausenloy, D. J., Boston-Griffiths, E., & Yellon, D. M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs131 · Cited by 152
Hinkel, R., El-Aouni, C., Olson, T., Horstkotte, J., Mayer, S., Müller;, S., Willhauck, M., Spitzweg, C., Gildehaus, F.-J., Münzing, W., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.758904 · Cited by 151
Cardioprotection by metabolic shut-down and gradual wake-up
Burwell, L. S., Nadtochiy, S. M., & Brookes, P. S. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.026 · Cited by 146
Reeve, J. L. V., Duffy, A. M., O'Brien, T., & Samali, A. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00492.x · Cited by 113
Pignataro, G., Scorziello, A., Di Renzo, G., & Annunziato, L. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06769.x · Cited by 100
Effects of nitrite on modulating ROS generation following ischemia and reperfusion
Raat, N. J. H., Shiva, S., & Gladwin, M. T. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.02.002 · Cited by 79
A time to reap, a time to sow: Mitophagy and biogenesis in cardiac pathophysiology
Andres, A. M., Stotland, A., Queliconi, B. B., & Gottlieb, R. A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.10.003 · Cited by 78
Ingram, T. E., Fraser, A. G., Bleasdale, R. A., Ellins, E. A., Margulescu, A. D., Halcox, J. P., & James, P. E. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.050 · Cited by 69
Nuclear-encoded mitochondrial proteins and their role in cardioprotection
Boengler, K., Heusch, G., & Schulz, R. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.009 · Cited by 68
“In ischemic preconditioning, infarct size following sustained ischemia and reperfusion is decreased by preceding, non-lethal episodes of ischemia/reperfusion [91], whereas in ischemic postconditioning, the brief cycles of ischemia and reperfusion are employed at the immediate onset of reperfusion [139].”
BackgroundTherapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury
Fernandez Rico, C., Konate, K., Josse, E., Nargeot, J., Barrère-Lemaire, S., & Boisguérin, P. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.792885 · Cited by 45
Treatment of Oxidative Stress with Exosomes in Myocardial Ischemia
Liu, Y., Wang, M., Liang, Y., Wang, C., Naruse, K., & Takahashi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041729 · Cited by 42
Metadata
- Authors
- Zhao, Z.-Q., Corvera, J. S., Halkos, M. E., Kerendi, F., Wang, N.-P., Guyton, R. A., & Vinten-Johansen, J.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2003-08
- Volume
- 285
- Issue
- 2
- Pages
- H579-H588
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W2137445925
- Cited by
- 2,070
- References
- 30
- FWCI
- 30.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.